Home » ASTRAZENECA RECEIVES JAPAN APPROVAL FOR CFC-FREE CORTICOSTEROID INHALER FOR PAEDIATRIC ASTHMA
ASTRAZENECA RECEIVES JAPAN APPROVAL FOR CFC-FREE CORTICOSTEROID INHALER FOR PAEDIATRIC ASTHMA
Astrazeneca announced that it received approval for its Pulmicort Respules for pediatric asthma infants from 6 months to under 5 years old, from the Japanese Ministry of Health, Labor and Welfare. This is the first and only inhaled nebolized corcicosteroid approved for infants and children with asthma in Japan.
JCN Network (http://japancorp.net/Article.Asp?Art_ID=12968)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
07May
-
14May
-
30May